RG-1501

N/A

Report date: 2025/02/18 17:35:05

Base Information

Drug NameRG-1501
Drug Alias NameRG-1501RG1501
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionHuman leukocyte antigen modulators
TargetsHuman leukocyte antigen
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRheumaGen Inc
China Registration ClassN/A

Develop Information

Active CompaniesRheumaGen Inc
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A